Immune checkpoint inhibitor-related myasthenia gravis, myositis and myocarditis: a triad but not at the same time?

QJM. 2024 Jun 4;117(5):373-374. doi: 10.1093/qjmed/hcae006.

Authors

T Cooksley^{1

2}, J Weaver^{1

2}, M McNamara^{1

2}, P Lorigan^{1

2}

Affiliations

¹ The Christie NHS Foundation Trust, Manchester, UK.
² University of Manchester, Manchester, UK.

PMID: 38229249
DOI: 10.1093/qjmed/hcae006

No abstract available

Publication types

Case Reports

MeSH terms

Female
Humans
Immune Checkpoint Inhibitors* / adverse effects
Male
Middle Aged
Myasthenia Gravis* / chemically induced
Myasthenia Gravis* / drug therapy
Myocarditis* / chemically induced
Myositis* / chemically induced

Substances

Immune Checkpoint Inhibitors